IndraLab

Statements

YOD1 inhibits HNSCC. 4 / 4
| 4
reach
"The experimental outcomes show that high expression of YOD1 inhibits the malignant progression of HNSCC, and that low expression of YOD1 was related to poor prognosis."
37573347
reach
"Given its importance, YOD1 acts as a key DUB to suppress HNSCC progression."
37573347
reach
"The results of the in vitro and in vivo experiments verified that YOD1 depletion significantly promoted growth, invasion, and epithelial-mesenchymal transition in HNSCC."
37573347
reach
"Further research emphasized this theory that YOD1 inhibited the progression of HNSCC."
37573347